Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: February 11, 2021

  1. Home>
  2. 2021>
  3. February>
  4. 11
Alpha-synuclein Tests Have Been Improved for Parkinson’s Diagnosis
source: pixabay.com

Alpha-synuclein Tests Have Been Improved for Parkinson’s Diagnosis

  • Post author:Kendall Mason
  • Post published:February 11, 2021
  • Post category:Parkinson's Disease

An accumulation of alpha-synuclein is a major characteristic of Parkinson's disease, one that is often used to diagnose the condition. Current methods see medical professionals measuring the rate at which…

Continue Reading Alpha-synuclein Tests Have Been Improved for Parkinson’s Diagnosis
ASCO GU Presentation: Positive Data on Cabometyx for Renal Cell Carcinoma
source: pixabay.com

ASCO GU Presentation: Positive Data on Cabometyx for Renal Cell Carcinoma

  • Post author:Jessica Lynn
  • Post published:February 11, 2021
  • Post category:Renal Cell Carcinoma

  The American Society of Clinical Oncology will soon hold their Genitourinary Cancers Symposium (ASCO GU) from February 11 through 13, 2021. The symposium, held virtually during COVID-19, will feature…

Continue Reading ASCO GU Presentation: Positive Data on Cabometyx for Renal Cell Carcinoma
Approval Received for Essential Tremor Study
jarmoluk / Pixabay

Approval Received for Essential Tremor Study

  • Post author:Jessica Lynn
  • Post published:February 11, 2021
  • Post category:Essential Tremor

  In early February, global healthcare company Insightec shared that the company received FDA approval for its new study. Within the study, Insightec will evaluate Focused Ultrasound as a potential…

Continue Reading Approval Received for Essential Tremor Study
Generic Icatibant Now Available in U.S. for HAE
whitesession / Pixabay

Generic Icatibant Now Available in U.S. for HAE

  • Post author:Jessica Lynn
  • Post published:February 11, 2021
  • Post category:Hereditary Angiodema

  After in-licensing Icatibant, a Bradykinin B2 receptor agonist, from Slayback Pharma, global pharmaceutical and biosimilar leader Sandoz is launching a generic version in the United States. According to a…

Continue Reading Generic Icatibant Now Available in U.S. for HAE
Research Identifies Genetic Precursors to Rhabdomyosarcoma
Source: Pixabay

Research Identifies Genetic Precursors to Rhabdomyosarcoma

  • Post author:Jessica Lynn
  • Post published:February 11, 2021
  • Post category:Rhabdomyosarcoma- embryonal

According to Oncology Nursing News, a new study performed by researchers at the Baylor College of Medicine used germline testing to identify genetic precursors to pediatric rhabdomyosarcoma. The study identified…

Continue Reading Research Identifies Genetic Precursors to Rhabdomyosarcoma
Special Needs Students Deserve Quality Online Education

Special Needs Students Deserve Quality Online Education

  • Post author:Rose Duesterwald
  • Post published:February 11, 2021
  • Post category:Rare Disease

The COVID pandemic affecting eighty-million children in the nation has been a burden on many families. A number that deserves attention is the seven million students who have learning disabilities.…

Continue Reading Special Needs Students Deserve Quality Online Education
HER2 Positive Cancer Treatment Moves Into Expansion Study

HER2 Positive Cancer Treatment Moves Into Expansion Study

  • Post author:Kendall Mason
  • Post published:February 11, 2021
  • Post category:Cancer

Zymeworks Inc. has recently began enrollment for an expansion cohort of the Phase 1 trial of ZW49. ZW49 is an antibody-drug conjugate (ADC) that targets HER2 positive cancer cells. This…

Continue Reading HER2 Positive Cancer Treatment Moves Into Expansion Study
CALQUENCE Beneficial for CLL, Study Shows
DarkoStojanovic / Pixabay

CALQUENCE Beneficial for CLL, Study Shows

  • Post author:Jessica Lynn
  • Post published:February 11, 2021
  • Post category:Chronic Lymphocytic Leukemia

In a recent press release, biopharmaceutical company AstraZeneca announced that its drug CALQUENCE (acalabrutinib) met both its primary and secondary endpoints in the Phase 3 ELEVATE-RR clinical trial. These endpoints…

Continue Reading CALQUENCE Beneficial for CLL, Study Shows
Cerebral Palsy: These British Parents Fear Their 11-Year-Old May Lose His Cannabis Supply
source: pixabay.com

Cerebral Palsy: These British Parents Fear Their 11-Year-Old May Lose His Cannabis Supply

  • Post author:Sunniva Bean
  • Post published:February 11, 2021
  • Post category:Cerebral Palsy

For some parents, learning your child is using cannabis products might cause trouble or upset. Joanne Griffiths is troubled and upset because her son might lose his supply. According to…

Continue Reading Cerebral Palsy: These British Parents Fear Their 11-Year-Old May Lose His Cannabis Supply
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info